台股 » 個股 » 杏國 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

杏國

(4192)
  • 股價
    45.80
  • 漲跌
    ▼1.05
  • 漲幅
    -2.24%
  • 成交量
    21
  • 產業
    上櫃 生技醫療類股
  • 119人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
杏國 (4192)籌碼相關-凱基-三峽 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-三峽 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/08/1000.00748.0748.00-740-17.08%
2023/07/14748.1000.0049.5075213.36%
2023/05/2600.00218.0518.05-259-3.35%
2023/04/2500.00919.1519.30-960-14.87%
2023/03/22918.4200.0019.1095117.49%
2022/01/1400.00129.7029.40-1856-0.12%
2021/12/060.129.0000.0028.500.11,4790.00%
2021/11/220.136.0000.0036.000.11,5630.00%
2021/11/170.140.5000.0040.500.11,5180.01%
2021/11/1500.00136.5540.95-11,492-0.07%
2021/11/050.143.0500.0043.050.11,5010.00%
2021/11/030.153.1000.0053.100.11,3170.00%
2021/10/1800.001132.50132.50-11,376-0.07%
2021/10/141136.502131.00134.00-11,357-0.07%
2021/10/123129.0000.00128.0031,3390.22%
2021/10/071131.0000.00133.0011,3150.08%
2021/10/0600.002132.50131.00-21,303-0.15%
2021/10/051117.006117.17140.00-51,283-0.39%
2021/10/047138.9300.00129.5071,2350.57%
2021/09/2400.001109.00118.50-11,012-0.10%
2021/09/2200.0010105.00106.50-10962-1.04%
2021/09/161111.0000.00109.0019250.11%
2021/09/1400.001108.00103.00-1832-0.12%
2021/09/13190.10292.5098.20-1754-0.13%
2021/09/09288.90289.9589.1007150.00%
2021/09/08288.80192.8088.5017110.14%
2021/09/07186.20289.1591.20-1701-0.14%
2021/09/06289.45291.0589.4006770.00%
2021/09/03289.50291.0089.3006650.00%
2021/09/02289.50391.5390.80-1660-0.15%
2021/09/01490.63192.3090.2036520.46%
2021/08/31292.00390.7093.00-1641-0.16%
2021/08/30389.77389.0090.7006200.00%
2021/08/27387.93189.0088.5026080.33%
2021/08/26185.10694.8292.10-5581-0.86%
2021/08/251190.59490.0087.5075351.31%
2021/08/24486.601686.4489.40-12526-2.28%
2021/08/23290.00592.0290.00-3513-0.58%
2021/08/2000.00186.1086.10-1496-0.20%
2021/08/19881.5100.0078.3084821.66%
2021/08/18887.1000.0082.0084701.70%
2021/08/17288.3000.0088.0024520.44%
2021/08/16693.831290.0493.00-6439-1.36%
2021/08/13287.40286.4591.0004200.00%
2021/08/12282.45284.0086.1003970.00%
2021/08/11278.50979.0078.30-7365-1.92%
2021/08/061080.62280.3081.2083072.60%
2021/08/051273.6900.0073.90123043.95%
2021/06/0900.00050.1050.0003310.00%
2021/03/2900.00155.7057.40-1281-0.35%
2021/03/0300.001050.0049.95-10268-3.73%
2021/02/2600.00551.1851.10-5270-1.85%
2021/02/2500.001453.5453.00-14270-5.17%
2021/02/24155.50154.5055.0002640.00%
2021/02/2300.00151.3051.60-1266-0.37%
2021/02/193049.1200.0049.403025311.84%
2020/11/2300.00250.4050.50-2394-0.51%
2020/11/20256.1500.0052.5024010.50%
2020/11/1900.00155.1055.10-1397-0.25%
2020/11/0200.00148.5049.00-1523-0.19%
2020/10/2900.00149.8049.60-1559-0.18%
2020/10/28252.5500.0050.4025750.35%
2020/10/26149.1500.0048.6015780.17%
2020/10/23051.0000.0050.8005880.00%
2020/10/2000.00251.3051.40-2609-0.33%
2020/09/2500.00260.8560.30-2746-0.27%
2020/09/24263.4500.0061.5027560.26%
2020/09/21164.90165.2065.0007830.00%
2020/09/18163.70163.8066.2007900.00%
2020/09/17162.9000.0062.2018060.12%
2020/09/1100.00163.7063.00-1840-0.12%
2020/09/0300.00172.4071.40-1949-0.11%
2020/09/0100.00176.1075.40-1949-0.11%
2020/08/31477.60277.5077.2029460.21%
2020/08/27183.0000.0080.0019390.11%
2020/08/26177.9000.0082.3019280.11%
2020/08/06190.50995.6086.20-8824-0.97%
2020/07/2200.00173.1073.10-1671-0.15%
2020/07/2100.00168.0066.50-1667-0.15%
2020/07/161090.5000.0091.00106181.62%
2020/07/1500.001100.50100.50-1597-0.17%
2020/07/101127.003140.33137.00-2552-0.36%
2020/06/3000.00171.0073.00-1445-0.22%
2020/06/19169.5000.0067.9013570.28%
2020/06/1500.00358.1361.60-3270-1.11%
2020/06/1200.00155.8056.00-1251-0.40%
2020/06/11356.83156.4056.7022250.89%
2020/06/10154.3000.0054.4011820.55%
2020/06/0300.00138.2538.65-1124-0.80%
2020/06/0100.00138.1039.50-1116-0.86%
2020/05/28137.2500.0036.2511040.96%
2020/05/2700.00334.8036.15-3100-2.97%
2020/05/26337.2000.0036.003973.07%
2020/05/25134.1000.0035.351871.15%
2019/01/1500.00125.6025.50-148-2.06%
2019/01/0800.00125.5025.25-145-2.21%
2019/01/0400.00324.5024.70-343-6.83%
2018/10/25524.6000.0025.105519.73%
杏國將在歐洲腫瘤內科學會亞洲年會 發表胰臟癌臨床結果UDN聯合新聞網-2022/09/25
杏國胰臟癌新藥三期試驗喊卡 待美FDA通知補件Anue鉅亨-2022/05/18
杏國 相關文章